Gene therapy shows significant improvement in Parkinson's disease

Neurologix, Inc. today announced the publication in the June 23 issue of the journal The Lancet of positive results from the first ever gene therapy trial for Parkinson’s disease and the first report of direct gene transfer into a patient’s own brain cells for any adult neurodegenerative disease.

If you want to include this story in your blog, copy and paste this formatted text: